{"id":"W4226403841","doi":"10.1007/s10637-022-01227-5","title":"Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA","year":2022,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Orphan drug; Cancer drugs; Food and drug administration; Drug approval; Clinical trial; Confidence interval; Odds ratio; Clinical research; Cancer; Family medicine; Drug; Internal medicine; Environmental health; Pharmacology; Bioinformatics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02235346,0.0002073075,0.0005418714,0.00291379,0.0008483293,0.001696197,0.0006642916,0.0007361002,0.005775475],"category_scores_gemma":[0.05631479,0.0002042191,0.0008611628,0.003465192,0.001352052,0.0007003236,0.0009001803,0.001345125,0.0003731994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01136342,"about_ca_system_score_gemma":0.04203346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2590687,"about_ca_topic_score_gemma":0.413136,"domain_scores_codex":[0.9813541,0.005770568,0.001186307,0.001396828,0.008568676,0.001723487],"domain_scores_gemma":[0.8795256,0.04890959,0.02630805,0.003167865,0.03321516,0.008873688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006279803,0.0002344107,0.688145,0.003305123,0.001100846,0.0006203809,0.0007704201,0.001099369,0.002442659,0.007808848,0.03418013,0.2540129],"study_design_scores_gemma":[0.0004921986,0.0008744659,0.9249225,0.001284817,0.0007192988,0.0009876824,0.000767782,0.001055699,0.001725525,0.0008601273,0.06625325,0.00005669666],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7601342,0.06491073,0.003677669,0.02088273,0.0004674798,0.001339033,0.01034656,0.0002235215,0.1380181],"genre_scores_gemma":[0.979472,0.00810625,0.003360569,0.003004286,0.0001022778,0.0001346218,0.001708453,0.00002736682,0.004084146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2590687,"threshold_uncertainty_score":0.5151216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.148947661525033,"score_gpt":0.3762924999720464,"score_spread":0.2273448384470134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}